At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 886 enrolled
Drug / intervention
Levocetirizine +1 moredrug
Likely dose
Levocetirizine 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU)
In Brief
A Phase 4 clinical trial evaluating Levocetirizine and Desloratadine for Chronic Idiopathic Urticaria. Completed, enrolled 886 participants across 80 sites in 9 countries.
Detailed Summary
A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over the first week of treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Idiopathic Urticaria
CountriesBelgium, France, Germany, Italy, Malaysia, Romania, South Africa, Spain, United Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2005
First PostedDec 2005
Primary CompletionJan 2007
TodayJul 2026
First PostedDec 12, 2005
Enrollment StartDec 1, 2005
Primary CompletionJan 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.6 years ago
Interventions
Levocetirizinedrug
5mg oral capsules, once daily, 4 week duration
Desloratadinedrug
5mg oral capsules, once daily, 4 week duration